Press Releases

Date Title and Summary Additional Formats
Toggle Summary UCB Selects Medidata Clinical Cloud® to Support Patient-Centric Drug Development
Medidata's Cutting-Edge Technology Platform to Drive Operational Excellence and Patient Value for Global Biopharma NEW YORK --(BUSINESS WIRE)-- Medidata (NASDAQ:MDSO), the leading global provider of cloud-based solutions and data analytics for clinical research, today announced that UCB has
View HTML
Toggle Summary WuXi Clinical Development Services Expands Use of Medidata's Cloud Technology Platform
Leading Global Pharmaceutical, Biopharmaceutical and Medical Device Open-access Capability and Technology Platform Company Adopts Medidata's Cloud-based Study Conduct Solutions NEW YORK --(BUSINESS WIRE)-- Medidata (NASDAQ:MDSO), the leading global provider of cloud-based solutions for clinical
View HTML
Toggle Summary Medidata to Acquire Mytrus to Take Next Step in Transforming the Clinical Trial Patient Experience
Mytrus eConsent to be Added to Patient Cloud Product Suite NEW YORK --(BUSINESS WIRE)-- Medidata (NASDAQ:MDSO), the leading global provider of cloud-based solutions and data analytics for clinical research, today announced that the company has agreed to acquire Mytrus, Incorporated , an e-clinical
View HTML
Toggle Summary Medidata Schedules First Quarter Earnings Conference Call for April 26, 2017
NEW YORK --(BUSINESS WIRE)-- Medidata (NASDAQ:MDSO), the leading global provider of cloud-based technology and data analytics for clinical research, today announced that it will release its first quarter 2017 financial results before the open of the market on Wednesday, April 26, 2017 .
View HTML
Toggle Summary Medidata Wins Informa CARE Award for "Clinical Trial Partnership of the Year"
NEW YORK --(BUSINESS WIRE)-- Medidata (NASDAQ:MDSO), the leading global provider of cloud-based technology and data analytics for clinical research, is pleased to announce that its unique technology collaboration with TESARO, Inc. was recognized as the 2017 "Clinical Partnership of the Year" at the
View HTML
Toggle Summary Karyopharm and Medidata Expand Clinical Trial Partnership
Oncology-Focused Pharmaceutical Company Taps into Medidata's Machine-Learning Technology to Pursue Better Clinical Trials for Cancer Therapies NEW YORK --(BUSINESS WIRE)-- Medidata (NASDAQ:MDSO) and clinical-stage pharmaceutical company Karyopharm Therapeutics (NASDAQ:KPTI) today announced an
View HTML
Toggle Summary Medidata's Clinical Technology Platform Selected for Groundbreaking "Beat AML Master Trial"
Medidata Provides Technology Infrastructure to Power Clinical Research on Acute Myeloid Leukemia, Accelerating Hope for New Blood Cancer Treatment NEW YORK --(BUSINESS WIRE)-- Medidata , the leading global provider of cloud-based technology and data analytics for clinical research, today announced
View HTML
Toggle Summary Medidata and INC Research Expand Technology Partnership
Leading Global CRO and Medidata Mark 10-Year Anniversary Milestone With Multi-Year Partnership Extension and Expansion INC Research Adopts Medidata Centralized Statistical Analytics (CSA) to Provide Immediate Insight into Trial Site Performance and Data Quality RALEIGH, N.C.
View HTML
Toggle Summary Medidata and Medical Device Innovation Consortium Partner to Help Drive Change in the Medical Technology Space
Medidata Joins First-Ever Public-Private Partnership to Improve Patient Access to Life-Changing Medical Device Solutions NEW YORK --(BUSINESS WIRE)-- Medidata (NASDAQ:MDSO), the leading global provider of cloud-based solutions and data analytics for clinical research, today announced that the
View HTML
Toggle Summary Medidata to Present at Upcoming Investor Conferences
NEW YORK --(BUSINESS WIRE)-- Medidata (NASDAQ:MDSO), the leading global provider of cloud-based solutions for clinical research in life sciences, today announced that the company will present at the following upcoming investor conferences. Rouven Bergmann , chief financial officer, will present at
View HTML

Investor Contact

Anthony D'Amico
Senior Director, Investor Relations
+1 732 767 4331
adamico@mdsol.com